Czechia, Feb. 20 -- Czechia based ROCHE s.r.o. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic and immunomodulating agents - LP s obsahem OBINUTUZUMABU 2024. The value of the contract is worth 3646118700 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....